Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Chronic Postoperative Pain
NCT03275207Phase 4Unknown
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Jan 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in chronic post-surgical pain (CPSP) (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Pain Intensity Measure at 12 months. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
chronic post-surgical pain (CPSP)
Beyond the preview
Go deeper on NCT03275207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03275207.